Financial Summary for the Third Quarter of Fiscal Year Ending May 2026 [Japanese GAAP] (Consolidated)

Overview of Performance

In the consolidated cumulative period of the third quarter of the fiscal year ending May 2026, net sales totaled 422,807 million yen (13.7% increase YoY), operating income was 21,420 million yen (7.4% increase YoY), ordinary income reached 21,835 million yen (6.6% increase YoY), and net income attributable to owners of the parent was 15,376 million yen (10.3% increase YoY). The increase in sales was mainly due to the expansion of store count and food category. The group operated a total of 1,095 stores comprising 1,073 drugstores (692 with dispensing pharmacies), 6 dispensing-only pharmacies, and 16 supermarkets. Although the equity ratio declined to 35.7%, the business performance remained solid.

Financial Position and Outlook

Total assets amounted to 388,578 million yen (an increase of 36,113 million yen from the previous fiscal year-end), and total liabilities were 249,835 million yen (an increase of 43,130 million yen), primarily due to an increase in long-term borrowings. Total net assets stood at 138,742 million yen (a decrease of 7,017 million yen). There are no revisions to the earnings guidance for the full fiscal year ending May 2026, which forecasts net sales of 560,000 million yen (11.7% increase YoY), operating income of 23,000 million yen (13.5% decrease YoY), and net income attributable to owners of parent of 15,500 million yen (12.9% decrease YoY). The dividend forecast includes a regular year-end dividend of 8 yen and a 40th anniversary commemorative dividend of 40 yen.